Patent Foramen Ovale Closure Market: Clinical Trial Outcomes to Play a Key Role

Patent Foramen Ovale Closure Market: Clinical Trial Outcomes to Play a Key Role. Over the last decade there has been considerable evidence gathered, relating Patent Foramen Ovales (PFO) to migraines, cryptogenic stroke and decompression sickeness. There is an increased frequency of PFO in patients suffering from migraine- a frequency that almost parallels the presence of PFO in stroke. Currently, PFO closure is indicated for prevention of recurring stroke due to embolisms. A string of clinical trials are now underway to establish the relation between PFO to migraine especially. A positive outcome establishing this relation in any of these trials will lead to an increased acceptance of PFO closure in patients with migraine, as opposed to temporary relief from drugs. The medical device industry is also bracing itself in hope of clinical trials like the PREMIUM, with a strong pipeline of improved PFO closure devices slated for release in the next couple of years. Aided by this pipeline and possible positive outcomes from the trials, the PFO market could position itself as one with high investment opportunities.

Scope

- Epidemiological data on the Patent Foramen Ovale (PFO) and its association with migrane
- Data on market characteristics and clinical trials conducted in this sector
- Review of key pipeline products related to PFO closure
- Key drivers and restraints of the global PFO closure market

Reasons to buy

- Design market entry and business strategies through insightful analysis of the global PFO closure market
- Understand market dynamics within the global PFO closure market
- Gain understanding of the key growth opportunities